Percutaneous nephrostomy in gynecologic oncology patients.
Percutaneous nephrostomies were used in 34 patients with ureteral obstruction caused by gynecologic diseases. Group 1 consisted of 12 patients with untreated cervical carcinoma; group 2 consisted of six patients with recurrent cervical carcinoma; group 3 consisted of seven patients with complications of urinary conduits, and group 4 consisted of eight patients with a variety of malignant and benign gynecologic diseases causing ureteral obstruction. One perinephric hematoma and one perinephric abscess (4%) occurred during primary percutaneous nephrostomy diversion of 53 renal units. One (3%) percutaneous nephrostomy-related death caused by sepsis was observed in 34 patients. Only four (12%) patients with significant intrinsic renal disease did not have effective normalization of renal function by percutaneous nephrostomy. Percutaneous nephrostomies allow rapid and reliable urinary diversion without the morbidity and mortality of operative techniques. Percutaneous nephrostomy should be considered for relief of ureteral obstruction in patients with untreated cervical carcinoma who may enjoy prolonged palliation or cure, in patients with complications of previous urinary conduits as a temporizing method of urinary diversion, and in patients with benign or chemotherapy-sensitive pelvic malignancies causing ureteral obstruction. The use of percutaneous nephrostomy in patients with recurrent carcinoma of the cervix should be individualized on the basis of expectations for prolonged functional palliation.
D005260:Female; D005833:Genital Neoplasms, Female / Q000150:complications*; D006801:Humans; D009364:Neoplasm Recurrence, Local; D009403:Nephrostomy, Percutaneous / Q000009:adverse effects; D010166:Palliative Care; D012008:Recurrence; D014517:Ureteral Obstruction / Q000209:etiology / Q000628:therapy*; D014546:Urinary Catheterization / Q000379:methods*; D014547:Urinary Diversion; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000473:pathology